摘要
本文从“生熟异治”中药饮片品种功效差异、炮制目的出发,分析“生熟异治”中药炮制生产控制的风险点,并提出生产控制的思考和监管建议。
This article begins by examining the differences in efficacy among various types of traditional Chinese herbal pieces,as well as the purposes of processing,based on the principle of“differing treatments for raw and processed herbs”.It analyzes the risk points in production control during their processing and offers insights and regulatory recommendations for improving production control.
作者
王惠华
吴斌
周坛树
WANG Huihua;WU Bin;ZHOU Tanshu(Shanghai Center for Drug Evaluation and Inspection,Shanghai 201210,China)
出处
《上海医药》
2025年第2期72-75,共4页
Shanghai Medical & Pharmaceutical Journal
关键词
生熟异治
中药炮制
风险控制
监管建议
differing treatments for raw and processed herbs
traditional Chinese herbal pieces processing
risk management
regulatory recommendation
